Distribution of a COPD population based on the GOLD assessment framework

G. Nadeau, P.W. Jones, L. Adamek, M. Small (Uxbridge, , Macclesfield, United Kingdom)

Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Session: Prevalences and characterstics of obstructive airway disease
Session type: Poster Discussion
Number: 4748
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Nadeau, P.W. Jones, L. Adamek, M. Small (Uxbridge, , Macclesfield, United Kingdom). Distribution of a COPD population based on the GOLD assessment framework. Eur Respir J 2012; 40: Suppl. 56, 4748

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Distribution of COPD patients in the GOLD assessment framework by exacerbations
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012

The distribution of COPD in general practice using three different GOLD classification
Source: International Congress 2018 – COPD around the world
Year: 2018


The distribution of COPD in UK general practice using the new GOLD classification
Source: Eur Respir J 2014; 43: 993-1002
Year: 2014



Stability of the exacerbation pattern defined by GOLD 2017 in a real-world COPD population
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Combined COPD assessment using the new GOLD guidelines
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012




Validation of non-spirometric predictors of COPD to the GOLD stage classification
Source: Eur Respir J 2002; 20: Suppl. 38, 123s
Year: 2002

Validation of the GOLD 2017 classification in a Chinese COPD cohort
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017


Implementation of the GOLD 2017 disease classification in a real-life COPD cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Prediction of the clinical course of COPD using the old and the new GOLD classification
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

The distribution of COPD in UK general practice using the 2017 GOLD classification
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017


Population impact of different definitions of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 201s
Year: 2001

FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts
Source: Eur Respir J 2013; 42: 1391-1401
Year: 2013



Population based study on the prevalence of COPD by spirometric criteria
Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD
Year: 2010


GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results
Source: Eur Respir J 2005; 26: Suppl. 49, 69s
Year: 2005

Efficacy of revefenacin based on GOLD 2017 categories: reanalysis of phase 3 data in patients with COPD
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019


Heterogeneity of group D in the new GOLD classification of COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016


Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment framework
Source: Annual Congress 2012 - COPD epidemiology
Year: 2012